Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Shimada

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Nuclear Medicine and Biology|October 1, 2013
Biodistribution and radiation dosimetry in humans of [¹¹C]FLB 457, a positron emission tomography ligand for the extrastriatal dopamine D₂ receptorYasuyuki Kimura, Hiroshi Ito, Takahiro Shiraishi, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|February 23, 2013
Central nervous system drug evaluation using positron emission tomographyMizuho Sekine, Jun Maeda, Hitoshi Shimada, et al.
Japanese Journal of Clinical Oncology|November 15, 2017
Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancerTakashi Seto, Fumihiko Hirai, Hideo Saka, et al.
Current Alzheimer Research|July 10, 2018
Amyloid and Tau Positron Emission Tomography in Suggested Diabetesrelated DementiaNaoto Takenoshita, Raita Fukasawa, Yusuke Ogawa, et al.
Journal of Neurology|May 30, 2019
In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer's diseaseTatsuhiro Terada, Masamichi Yokokura, Tomokazu Obi, et al.
Parkinsonism & Related Disorders|March 29, 2026
Striatal DAT and disease progression in Parkinson's disease: New evidence from autonomic dysfunctionHaohan Zhang, Rong Li, Yuxiang Jiao, et al.
BMC Geriatrics|December 12, 2023
Corticobasal syndrome mimicking Foix-Chavany-Marie syndrome with suggested 4-repeat tauopathy by tau PETKosei Nakamura, Yasuko Kuroha, Masahiro Hatakeyama, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2023
Association of Tooth Loss with Alzheimer's Disease Tau Pathologies Assessed by Positron Emission TomographyHideki Matsumoto, Kenji Tagai, Hironobu Endo, et al.
Investigational New Drugs|July 31, 2012
Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I studyHajime Asahina, Hiroshi Nokihara, Noboru Yamamoto, et al.
Investigational New Drugs|March 15, 2012
First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumoursYasuhito Fujisaka, Yusuke Onozawa, Takayasu Kurata, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Nuclear Medicine and Biology|October 1, 2013
Biodistribution and radiation dosimetry in humans of [¹¹C]FLB 457, a positron emission tomography ligand for the extrastriatal dopamine D₂ receptorYasuyuki Kimura, Hiroshi Ito, Takahiro Shiraishi, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|February 23, 2013
Central nervous system drug evaluation using positron emission tomographyMizuho Sekine, Jun Maeda, Hitoshi Shimada, et al.
Japanese Journal of Clinical Oncology|November 15, 2017
Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancerTakashi Seto, Fumihiko Hirai, Hideo Saka, et al.
Current Alzheimer Research|July 10, 2018
Amyloid and Tau Positron Emission Tomography in Suggested Diabetesrelated DementiaNaoto Takenoshita, Raita Fukasawa, Yusuke Ogawa, et al.
Journal of Neurology|May 30, 2019
In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer's diseaseTatsuhiro Terada, Masamichi Yokokura, Tomokazu Obi, et al.
Parkinsonism & Related Disorders|March 29, 2026
Striatal DAT and disease progression in Parkinson's disease: New evidence from autonomic dysfunctionHaohan Zhang, Rong Li, Yuxiang Jiao, et al.
BMC Geriatrics|December 12, 2023
Corticobasal syndrome mimicking Foix-Chavany-Marie syndrome with suggested 4-repeat tauopathy by tau PETKosei Nakamura, Yasuko Kuroha, Masahiro Hatakeyama, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2023
Association of Tooth Loss with Alzheimer's Disease Tau Pathologies Assessed by Positron Emission TomographyHideki Matsumoto, Kenji Tagai, Hironobu Endo, et al.
Investigational New Drugs|July 31, 2012
Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I studyHajime Asahina, Hiroshi Nokihara, Noboru Yamamoto, et al.
Investigational New Drugs|March 15, 2012
First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumoursYasuhito Fujisaka, Yusuke Onozawa, Takayasu Kurata, et al.
Pageof 10